A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z  

Ondreka, D.

Paper Title Page
MOPEA005 Status of the SIEMENS Particle Therapy Accelerators 70
 
  • P. Urschütz, O. Chubarov, S. Emhofer, S. Göller, K. Haß, C.M. Kleffner, V.L. Lazarev, M. Leghissa, M.T. Maier, D. Ondreka, H. Rohdjess, R. Rottenbach, A.C. Sauer, R. Schedler, B. Schlitt, P. Schütt, B. Steiner, J. Tacke, T. Uhl, U. Weinrich, O. Wilhelmi
    Siemens Med, Erlangen
  • H.K. Andersen, M. Budde, F. Bødker, J.S. Gretlund, H.B. Jeppesen, C.V. Nielsen, C.G. Pedersen, Ka.T. Therkildsen, S.V. Weber
    Siemens DK, Jyllinge
  • E. Tanke
    FRIB, East Lansing, Michigan
 
 

Siemens has earned three contracts to deliver IONTRIS Particle Therapy accelerator systems* to be operated in Marburg and Kiel, both in Germany, and in Shanghai, China. The accelerator part consists of an injector (7 MeV/u protons and light ions) and a compact synchrotron able to accelerate proton beams up to 250 MeV and carbon ions up to 430 MeV/u. These beams can be slowly extracted and delivered to a choice of fixed-angle horizontal, semi-vertical and vertical beam-ports. An overview of the design will be given and the status of the installation and commissioning work for the first two projects will be shown.


*Particle Therapy is a work in progress and requires country-specific regulatory approval prior to clinical use.